Viewing Study NCT01899859


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2026-01-27 @ 2:10 AM
Study NCT ID: NCT01899859
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2013-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Sponsor: Galectin Therapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Alcoholic Steatohepatitis (NASH) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Alcoholic Steatohepatitis (NASH) View